2005
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today responded to statements by Johnson & Johnson on its pending acquisition...
MULTI-LINK VISION® RX Coronary Stent System Provides Thin Struts, Superb Deliverability and Excellent Clinical Results Indianapolis, Ind. and Tokyo - Guidant Corporation (NYSE: GDT) today...
High Energy System Addresses Growing Physician Demand for More Defibrillation Energy Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT) today announced U.S. Food and Drug...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) said today that it is informing physicians about two separate failure modes, each occurring at a low rate, being monitored within the...
Indianapolis, Ind. - Guidant announced today that the U.S. Food and Drug Administration (FDA) has completed its inspection of Guidant's Cardiac Rhythm Management facilities in St. Paul, Minnesota,...